337 related articles for article (PubMed ID: 2521352)
1. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
Levitz SM; DiBenedetto DJ
J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
[TBL] [Abstract][Full Text] [Related]
2. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
Flesch IE; Schwamberger G; Kaufmann SH
J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
[TBL] [Abstract][Full Text] [Related]
3. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
Horwitz MA; Silverstein SC
J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
[TBL] [Abstract][Full Text] [Related]
4. Killing of Cryptococcus neoformans by rat alveolar macrophages.
Bolaños B; Mitchell TG
J Med Vet Mycol; 1989; 27(4):219-28. PubMed ID: 2677299
[TBL] [Abstract][Full Text] [Related]
5. [The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].
Tabeta H; Kohno N; Kamei K; Honda A; Unno H; Nagao K; Yamaguchi T; Miyaji M
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1174-9. PubMed ID: 1753544
[TBL] [Abstract][Full Text] [Related]
6. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
Bolaños B; Mitchell TG
J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
[TBL] [Abstract][Full Text] [Related]
7. Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils.
Richardson MD; White LJ; McKay IC; Shankland GS
J Med Vet Mycol; 1993; 31(3):189-99. PubMed ID: 8360810
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.
Zaragoza O; Taborda CP; Casadevall A
Eur J Immunol; 2003 Jul; 33(7):1957-67. PubMed ID: 12884862
[TBL] [Abstract][Full Text] [Related]
9. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.
Levitz SM; Tabuni A
J Clin Invest; 1991 Feb; 87(2):528-35. PubMed ID: 1991837
[TBL] [Abstract][Full Text] [Related]
10. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.
Cross CE; Bancroft GJ
Infect Immun; 1995 Jul; 63(7):2604-11. PubMed ID: 7790075
[TBL] [Abstract][Full Text] [Related]
11. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.
Levitz SM; DiBenedetto DJ
Infect Immun; 1988 Oct; 56(10):2544-51. PubMed ID: 3138176
[TBL] [Abstract][Full Text] [Related]
12. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
[TBL] [Abstract][Full Text] [Related]
13. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
Kozel TR; Gotschlich EC
J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
Zaragoza O; Casadevall A
Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
[TBL] [Abstract][Full Text] [Related]
15. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
Li RK; Mitchell TG
J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525
[TBL] [Abstract][Full Text] [Related]
16. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
Cross CE; Collins HL; Bancroft GJ
Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
[TBL] [Abstract][Full Text] [Related]
17. Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates.
Chaturvedi V; Wong B; Newman SL
J Immunol; 1996 May; 156(10):3836-40. PubMed ID: 8621921
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms.
Giles SS; Zaas AK; Reidy MF; Perfect JR; Wright JR
PLoS One; 2007 Dec; 2(12):e1370. PubMed ID: 18159253
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.
Granger DL; Perfect JR; Durack DT
J Immunol; 1986 Jan; 136(2):672-80. PubMed ID: 3510251
[TBL] [Abstract][Full Text] [Related]
20. Immunology of infection caused by Cryptococcus neoformans.
Wormley FL; Perfect JR
Methods Mol Med; 2005; 118():193-8. PubMed ID: 15888944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]